ProbiusDx
Company

Last deal

$3M

Amount

Series B

Stage

31.05.2023

Date

6

all rounds

$12.9M

Total amount

General

About Company
Probius is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations.

Industry

Sector :

Subsector :

founded date

01.01.2016

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Probius, founded in 2016 and based in Fermont, California, offers an all-electronic platform for fingerprinting biological specimens in preclinical and food safety applications. Their diagnostic technology allows for the detection and monitoring of blood concentrations, making it valuable in various healthcare and safety settings.